Clinical trial · Observational
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
NCT02887781CI-TRIAL-00072730TSARunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to investigate the factors (clinical, care-related and genetic) affecting renal outcome in patients with TSC (Tuberous sclerosis complex)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Tuberous Sclerosis Complex | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Evolution of the renal function estimated by the MDRD GFR
- timeFrame
- 18 months after inclusion
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 8 Years
Show eligibility criteria text
Inclusion criteria of study participants * Patient presenting with an isolated angiomyolipoma or * Patient presenting with tuberous sclerosis complex combined with an angiomyolipoma or * Patient presenting with tuberous sclerosis complex * Patient not objecting to the study Exclusion criteria of study participants ■Patient objecting to the study
References
Publications (0)
Data not yet available
No reference posted for this study.